E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/9/2015 in the Prospect News PIPE Daily.

Aeterna Zentaris prices $16.65 million public units offering at $5.55

Company sells units with five-year warrants via bookrunner Maxim Group

By Devika Patel

Knoxville, Tenn., Dec. 9 – Aeterna Zentaris Inc. said it priced a $16.65 million public sale of units with a $1.83 million greenshoe. The offering was announced Tuesday.

The company will sell 3 million units of one common share and 0.7 warrants at $5.55 per unit, with each whole warrant exercisable at $7.10 for five years. The strike price is identical to the Dec. 7 closing share price.

Maxim Group LLC is the bookrunner.

Settlement is expected Dec. 14.

Proceeds will be used for drug development, potential product additions, general corporate purposes and working capital.

Aeterna Zentaris is a specialty biopharmaceutical company based in Quebec.

Issuer:Aeterna Zentaris Inc.
Issue:Units of one common share and 0.7 warrants
Amount:$16.65 million
Greenshoe:$1,831,500, or 330,000 units
Units:3 million
Price:$5.55
Warrants:0.7 warrants per unit
Warrant expiration:Five years
Warrant strike price:$7.10
Bookrunner:Maxim Group LLC
Announcement date:Dec. 8
Pricing date:Dec. 9
Settlement date:Dec. 14
Stock symbol:Nasdaq: AEZS
Stock price:$7.10 at close Dec. 7
Market capitalization:$32.08 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.